Inhibition of integrin receptor by increasing concentrations and treatment durations with Cilengitide increases the sensitivity of killing in vivo of U87 glioma cancer cell xenograft mouse.
DOI:
https://doi.org/10.61173/hsv29020Keywords:
integrin αvβ3, Cilengitide, U87 glioma cancer cell, xenograft mouseAbstract
This study examined the effects of integrin αvβ3 on specific cell lines and xenograft mice. The experiment used female nude mice (BALB/c mice, four weeks old). The protein is collected in a lysis buffer containing phosphatase and protease inhibitors. Cell cycle distribution was measured by FACSCalibur flow cytometry, and MTT measures the activity of cells. The results of 12 combinations were described in this study. The results of this study indicated whether Cilengitide therapy can inhibit glioma proliferation in vitro and in vivo. To conclude, the results of this study also provided some insights into future research directions in the same field. The interaction mechanism between Cilengitide and gliomas can be further investigated to provide insights into the molecular pathways and may reveal additional therapeutic targets.
References
[1] National Health Commission of China, (2022) Brain glioma diagnosis and treatment guidelines. http://www.nhc.gov.cn/cmssearch/downFiles/2888d8e5c72c48ca8a9844000f55be58.pdf
[2] Lee, J. H., & Wee, C. W. (2022). Treatment of adult gliomas: A current update. Brain & Neurorehabilitation, 15(3). Shanghai Municipal Health Commission, Brain glioma, 2022, 7(3).
[3] Sijia Peng, Li Yi, (2022) Research progress on the role of integrin αvβ3 antagonists in cerebral ischemia-reperfusion injury, 29(2): R743.3.
[4] Mas‐Moruno, C., Fraioli, R., Rechenmacher, F., Neubauer, S., Kapp, T. G., & Kessler, H. (2016). αvβ3‐or α5β1‐integrin‐ selective peptidomimetics for surface coating. Angewandte Chemie International Edition, 55(25), 7048-7067.
[5] De Marco R, Tolomelli A, Juaristi EA. (2016) Integrin ligands with al-pha/ beta-Hybrid peptide structure: design, bioactivity, and conformational aspects. Medicinal Research Reviews, 36(3):389-424.
[6] Li Liu, Lijun Ding, (2017) Research progress of drugs targeting integrin αvβ3, Chinese Journal of New Medicine and Clinical Medicine, 36(9):505-510.
[7] Lowin T, Straub RH. (2011) Integrins and their ligands in rheumatoid arthritis. Arthritis Res Ther, 13(5):244.
[8] Madrazo, E., Conde, A.C. and Redondo-Munoz, J. (2017) Inside the Cell: Integrins as New Governors of Nuclear Alterations, Cancers, 9, 82.
[9] Hynes RO. (2002) Integrins: bidirectional, allosteric signaling machines. Cell, 110(6):673-687.
[10] Turaga RC, Yin L, Yang JJ, et al. (2016) Rational design of a protein that binds integrin alpha(v)beta(3) outside the ligand binding site. Nat Commun, 7:11675.
[11] Jiao, Y., Feng, X., Zhan, Y., Wang, R., Zheng, S., Liu, W., & Zeng, X. (2012) Matrix metalloproteinase-2 promotes αvβ3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin. Plos one, 7(7): e41591
[12] Ma Y, Ai GH, Zhang CY, et al. (2017) Novel linear peptides with high affinity to alpha v beta 3 integrin for precise tumor identifica-tion. Theranostics 7(6):1511-1523.
[13] Avraamides CJ, Garmy-Susini B, Varner JA. (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer, 8(8): 604-617.
[14] Brooks PC, Clark RA, Cheresh DA. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science, 264 (5158):569-571.
[15] Shimamura N, Matchett G, Yatsushige H, et al. (2006) Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke, 37(7):1902-1909.
[16] Linqing Lu, Ting Fang, Da Zhou, Xiaoxin Tong, et al. (2016) Dean&Francis Mechanism of action of Cilengitide, integrin αvβ3 inhibitor, in acute cerebral ischemia in rats [J], Chinese Medical Journal, 96(7):559-564.
[17] Sumiko Denda and Louis F. (2007) Reichardt, Methods Enzymol. 426: 203–221.
[18] Le Douarin NM, Dupin E. (2003) Multipotentiality of the neural crest. Current Opinion Journals 13:529–536.
[19] Kil SH, Krull CE, Cann G, Clegg D, Bronner-Fraser M. (1998) The alpha4 subunit of integrin is important for neural crest cell migration. Developmental. Biology.; 202:29–42.
[20] Tucker RP. (2004) Antisense knockdown of the beta1 integrin subunit in the chicken embryo results in abnormal neural crest cell development. International Journal of Biochemistry & Cell Biology 36:1135–1139.
[21] Pietri T, Eder O, Breau MA, Topilko P, Blanche M, Brakebusch C, Fassler R, Thiery JP, Dufour S. (2004) Conditional beta1-integrin gene deletion in neural crest cells causes severe developmental alterations of the peripheral nervous system. Development. 131:3871–3883.
[22] Feltri ML, Graus Porta D, Previtali SC, Nodari A, Migliavacca B, Cassetti A, Littlewood-Evans A, Reichardt LF, Messing A, Quattrini A, Mueller U, Wrabetz L. (2002) Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. Journal of cell biology. 156:199–209.
[23] Campos LS, Leone DP, Relvas JB, Brakebusch C, Fassler R, Suter U, Ffrench-Constant C. (2004) Beta1 integrins activate a MAPK signalling pathway in neural stem cells that contributes to their maintenance. Development. 131:3433–3444.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
